Login / Signup

Effects of SGLT2 inhibitor on tumor-releasing chemokines/cytokines in Hep3B and Huh7 cells.

Dan NakanoTakumi KawaguchiTsubasa TsutsumiMasako HayakawaSachiyo YoshioHironori KogaTakuji Torimura
Published in: JGH open : an open access journal of gastroenterology and hepatology (2022)
(a) Summary for SGLT2i-induced alterations in 48 chemokines/cytokines in Hep3B and Huh7 cells. (b) SGLT2i-induced changes in the medium CXCL1 level (each n  = 4). (c) SGLT2i-induced changes in the medium CXCL8 level (each n  = 4). (d) SGLT2i-induced changes in the medium CXCL10 level (each n  = 4), (e) SGLT2i-induced changes in the medium M-CSF level (each n  = 4). The SGLT2i-induced significant changes in chemokines/cytokines are expressed as the percentage of control (the mean value of the control was set as 100%). CXCL, C-X-C motif chemokine ligand; G-CSF, granulocyte colony-stimulating factor; IL, interleukin; LIF, leukemia inhibitory factor; M-CSF, macrophage colony-stimulating factor; MIP-1α, macrophage inflammatory protein-1α; SDF-1α, stromal-cell-derived factor-1α; TNFα, tumor necrosis factor-α; VEGF, vascular endothelial growth factor.
Keyphrases
  • vascular endothelial growth factor
  • induced apoptosis
  • high glucose
  • endothelial cells
  • bone marrow
  • adipose tissue
  • oxidative stress
  • diabetic rats
  • drug induced
  • peripheral blood
  • cell proliferation